Literature DB >> 26530167

Metabolism of benzo(a)pyrene by aortic subcellular fractions in the setting of abdominal aortic aneurysms.

A Ramesh1, P A Prins2, P R Perati2, P V Rekhadevi3, U K Sampson2,4,5.   

Abstract

As exposure to polycyclic aromatic hydrocarbons (PAHs; a family of environmental toxicants) have been implicated in cardiovascular diseases, the ability of the aortic tissue to process these toxicants is important from the standpoint of abdominal aortic aneurysms and atherosclerosis. Benzo(a)pyrene (B(a)P), a representative PAH compound is released into the environment from automobile exhausts, industrial emissions, and considerable intake of B(a)P is also expected in people who are smokers and barbecued red meat eaters. Therefore, knowledge of B(a)P metabolism in the cardiovascular system will be of importance in the management of vascular disorders. Toward this end, subcellular fractions (nuclear, cytosolic, mitochondrial, and microsomal) were isolated from the aortic tissues of Apo E mice that received a 5 mg/kg/week of B(a)P for 42 days and 0.71 mg/kg/day for 60 days. The fractions were incubated with 1 and 3 μM B(a)P. Post incubation, samples were extracted with ethyl acetate and analyzed by reverse-phase HPLC. Microsomal B(a)P metabolism was greater than the rest of the fractions. The B(a)P metabolite levels generated by all the subcellular fractions showed a B(a)P exposure concentration-dependent increase for both the weekly and daily B(a)P treatment categories. The preponderance of B(a)P metabolites such as 7,8-dihydrodiol, 3,6-, and 6,12-dione metabolites are interesting due to their reported involvement in B(a)P-induced toxicity through oxidative stress.

Entities:  

Keywords:  Aortic aneurysms; ApoE mouse; Atherosclerosis; Benzo(a)pyrene; Subcellular fractions

Mesh:

Substances:

Year:  2015        PMID: 26530167     DOI: 10.1007/s11010-015-2600-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Quantitative estimates of the variability of in vivo sonographic measurements of the mouse aorta for studies of abdominal aortic aneurysms and related arterial diseases.

Authors:  Uchechukwu K Sampson; Prudhvidhar R Perati; Petra A Prins; Wellington Pham; Zhouwen Liu; Frank E Harrell; MacRae F Linton; John C Gore; Valentina Kon; Sergio Fazio
Journal:  J Ultrasound Med       Date:  2011-06       Impact factor: 2.153

2.  Characterization of cytochrome oxidase purified from rat liver.

Authors:  I Z Ades; J Cascarano
Journal:  J Bioenerg Biomembr       Date:  1977-08       Impact factor: 2.945

3.  Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.

Authors:  Fumitake Usui; Koumei Shirasuna; Hiroaki Kimura; Kazuki Tatsumi; Akira Kawashima; Tadayoshi Karasawa; Koichi Yoshimura; Hiroki Aoki; Hiroko Tsutsui; Tetsuo Noda; Junji Sagara; Shun'ichiro Taniguchi; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

4.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Biomarkers of exposure to combustion by-products in a human population in Shanxi, China.

Authors:  Ziad Naufal; Li Zhiwen; Li Zhu; Guo-Dong Zhou; Thomas McDonald; Ling Yu He; Laura Mitchell; Aiguo Ren; Huiping Zhu; Richard Finnell; Kirby C Donnelly
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-03-11       Impact factor: 5.563

6.  Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.

Authors:  Kangting Ji; Yong Zhang; Fengchun Jiang; Lu Qian; Huihui Guo; Jianjian Hu; Lianming Liao; Jifei Tang
Journal:  J Vasc Surg       Date:  2013-05-12       Impact factor: 4.268

7.  Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses benzo(a)pyrene-accelerated atherosclerosis.

Authors:  Hong Yang; LiChun Zhou; Zefen Wang; L Jackson Roberts; Xinghua Lin; Yanfeng Zhao; ZhongMao Guo
Journal:  Atherosclerosis       Date:  2009-04-11       Impact factor: 5.162

8.  Exposure assessment of workers to airborne PCDD/Fs, PCBs and PAHs at an electric arc furnace steelmaking plant in the UK.

Authors:  Eric Aries; David R Anderson; Raymond Fisher
Journal:  Ann Occup Hyg       Date:  2008-04-08

9.  Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages.

Authors:  Manabu Matsunawa; Daisuke Akagi; Shigeyuki Uno; Kaori Endo-Umeda; Sachiko Yamada; Kazumasa Ikeda; Makoto Makishima
Journal:  Drug Metab Dispos       Date:  2012-07-25       Impact factor: 3.922

Review 10.  The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.

Authors:  Tom Lynch; Amy Price
Journal:  Am Fam Physician       Date:  2007-08-01       Impact factor: 3.292

View more
  2 in total

Review 1.  Benzo(a)pyrene and cardiovascular diseases: An overview of pre-clinical studies focused on the underlying molecular mechanism.

Authors:  Chenghao Fu; Yuemin Li; Hao Xi; Zemiao Niu; Ning Chen; Rong Wang; Yonghuan Yan; Xiaoruo Gan; Mengtian Wang; Wei Zhang; Yan Zhang; Pin Lv
Journal:  Front Nutr       Date:  2022-08-04

2.  Challenges in Predicting the Change in the Cumulative Exposure of New Tobacco and Related Products Based on Emissions and Toxicity Dose-Response Data.

Authors:  Yvonne C M Staal; Wieneke Bil; Bas G H Bokkers; Lya G Soeteman-Hernández; W Edryd Stephens; Reinskje Talhout
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.